Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol (Bluebird)

This study has been completed.
Sponsor:
Collaborators:
CreaNutrition, AG
University of Guelph
University of Sydney
Laval University
Reading Scientific Services Ltd.
University of Toronto
Agriculture and Agri-Food Canada
Information provided by:
Glycemic Index Laboratories, Inc
ClinicalTrials.gov Identifier:
NCT00981981
First received: September 18, 2009
Last updated: June 20, 2011
Last verified: June 2011